CSL Behring has marquee status in Australia where its parent CSL Ltd. ranks as the eighth largest company on the Australian stock exchange, but off its home turf the pharma firm is not well known. “We’re kind of the biggest company nobody has ever heard of,” quipped CEO Paul Perreault.
CSL is working to change that. The group is about to finalize its acquisition of Novartis AG’s flu business,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?